Merck's recent misstep in kidney cancer treatment bodes well for rival Exelixis, sending ripples through the pharma industry. But what does this shift mean for the wider market, and how can crypto enthusiasts glean insights from this biotech battle?
May 6, 2026
May 6, 2026
May 6, 2026
May 6, 2026
May 6, 2026
May 6, 2026
May 6, 2026
May 6, 2026